Impact Biomedical Quote - IBO

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

2.26

Bid

Ask

Volume

31,824

1.895 Day's Range 2.39

1.22 52 Week Range 3.25

Previous Close

2.32

Open

2.24

Last Trade

100

2.26

Last Trade Time

17:30:00

Average Volume (3m)

68,849

Financial Volume

US$ 68,957

VWAP

2.1668

Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a significant milestone in its innovative Linebacker™ technology platform. The Canadian...

Form 8-K - Current report

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...

Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (“IBO”) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled “Insect...

Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth

NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting unique healthcare...

Form 8-K - Current report

Impact BioMedical Inc. Announces the Closing of its Initial Public Offering

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today announced...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.07	3.19634703196	2.19	2.45	1.77	21898	2.21395647	CS
4	-0.38	-14.3939393939	2.64	3.06	1.58	32490	2.45193304	CS
12	-0.17	-6.99588477366	2.43	3.25	1.22	68849	2.23604335	CS
26	-0.74	-24.6666666667	3	3.25	1.22	81733	2.30105982	CS
52	-0.74	-24.6666666667	3	3.25	1.22	81733	2.30105982	CS
156	-0.74	-24.6666666667	3	3.25	1.22	81733	2.30105982	CS
260	-0.74	-24.6666666667	3	3.25	1.22	81733	2.30105982	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EFSH1847 Holdings LLC	US$ 0.3444 (53.34%)	2.04M
PAPLPineapple Financial Inc	US$ 0.46 (6.98%)	427
JQUAJpmorgan US Quality Factor ETF	US$ 62.61 (5.87%)	69.55k
MYNDMynd ai Inc	US$ 1.98 (5.83%)	942
CTMCastellum Inc	US$ 0.309 (5.82%)	22.67k
YCBDcbdMD Inc	US$ 0.405 (-7.74%)	101.58k
CPHIChina Pharma Holdings Inc	US$ 0.18 (-6.40%)	888
LPALogistic Properties of the Americas	US$ 9.66 (-5.29%)	1.33k
BTTRBetter Choice Company Inc	US$ 1.95 (-5.25%)	526
AIMAIM ImmunoTech Inc	US$ 0.20 (-4.99%)	24.13k
SPYSPDR S&P 500	US$ 604.0899 (-0.03%)	15.53M
FXIiShares China Large Cap	US$ 30.641 (-0.06%)	14.89M
IVViShares Core S&P 500	US$ 604.43 (-0.11%)	13.89M
USCAXtrackers Msci US Climate Action Equity ETF	US$ 38.341 (0.00%)	6.8M
XLFFinancial Select Sector	US$ 49.10 (0.00%)	5.03M